Search

everythinglearnresearchcommunity

for

Search:↓

Females have higher Dechlorane Plus in hair, while males have more in dorm dust.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

C57BL/6 mice and SD rats have different sweat gland and hair follicle patterns, useful for skin research.

Children with pituitary dwarfism have higher zinc and copper, lower manganese, and similar iron levels in hair compared to normal children.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

Measuring 24-OHase induction helps identify defects in vitamin D processing and predict treatment response.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Shorter GGC triplet repeats in the androgen receptor gene are linked to less hair loss in Han men.

A new model helps predict treatment success in girls with early puberty.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Most skin conditions in Down syndrome are benign and involve dry or thickened skin.

Primary care providers should understand Geschlechtsinkongruenz to offer better care for transitioning individuals.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.